Experts Warn Against High-Dose Nicotinamide for Glaucoma Due to Liver Risks
The American Glaucoma Society (AGS) and the American Academy of Ophthalmology (AAO) have issued a cautionary statement regarding the use of nicotinamide (a derivative of vitamin B3) as a potential therapy for glaucoma neuroprotection. While it shows promise for protecting the optic nerve, concerns about its safety—particularly the risk of drug-induced liver injury (DILI)—make careful […]







